These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Hyseq-Variagenics merger signals end of the line. Hodgson J Nat Biotechnol; 2003 Jan; 21(1):5. PubMed ID: 12511895 [No Abstract] [Full Text] [Related]
33. Michigan's next wave of biopharmaceutical entrepreneurship. Kerppola R; van de Walle M; Surine S Nat Biotechnol; 2003 Sep; 21(9):1109-11. PubMed ID: 12949575 [No Abstract] [Full Text] [Related]
34. A very firm handshake: biotech's growing negotiating power. Thiel KA Nat Biotechnol; 2005 Oct; 23(10):1221-6. PubMed ID: 16211058 [No Abstract] [Full Text] [Related]
37. Life sciences venture capital in emerging markets. Chakma J; Sammut SM; Agrawal A Nat Biotechnol; 2013 Mar; 31(3):195-201. PubMed ID: 23471064 [No Abstract] [Full Text] [Related]
38. From the analyst's couch: The outlook for biotech exits. Grimaldi A Nat Biotechnol; 2014 Mar; 32(3):227-8. PubMed ID: 24727772 [No Abstract] [Full Text] [Related]
39. Genzyme-Sanofi buy out is second largest biotech deal ever. Ratner M Nat Biotechnol; 2011 Apr; 29(4):293-4. PubMed ID: 21478828 [No Abstract] [Full Text] [Related]